Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124214) titled 'A study exploring the immunogenicity and safety of different immunization schedules for the 13-valent pneumococcal polysaccharide conjugate vaccine' on May 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangxi Center for Disease Prevention and Control
Condition:
Pneumococcal disease caused by Streptococcus pneumoniae
Intervention:
A:2 doses(1P+1)
B:2 doses(1P+1)
C:3 doses(2P+1)
D:3 doses(2P+1)
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-09-25
Target Sample Size: A:110;B:110;C:110;D:110;E:110;
Countries of Recruitment:
China
To know more, vis...